Richard J. Napolitano - 01 Apr 2022 Form 4/A - Amendment Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
02 May 2022, 16:12:43 UTC
Date Of Original Report
04 Apr 2022
Previous filing
02 Mar 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Award $0 +6,778 $0.000000 6,778 01 Apr 2022 Common Stock 6,778 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2 One-third of the restricted stock units vest on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F3 On April 4, 2022, the reporting person filed a Form 4 which inadvertently reported that the restricted stock units will vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, instead of on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.